226 related articles for article (PubMed ID: 16782218)
1. The future of gene therapy in the UK.
Seymour LW
Trends Biotechnol; 2006 Aug; 24(8):347-9. PubMed ID: 16782218
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy: cursed or inching towards credibility?
Branca MA
Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
[No Abstract] [Full Text] [Related]
3. Unlocking the money-making potential of RNAi.
Howard K
Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
[No Abstract] [Full Text] [Related]
4. [Gene therapy - successes and many unsolved questions].
Bruhn C
Dtsch Med Wochenschr; 2014 Sep; 139(39):1916-7. PubMed ID: 25360466
[No Abstract] [Full Text] [Related]
5. Recent patent applications in microRNAs.
Nat Biotechnol; 2006 Jan; 24(1):44. PubMed ID: 16404392
[No Abstract] [Full Text] [Related]
6. How will biotechnology fare in pharma's big plan?
Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
[No Abstract] [Full Text] [Related]
7. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
8. Genetic engineering of filamentous fungi--progress, obstacles and future trends.
Meyer V
Biotechnol Adv; 2008; 26(2):177-85. PubMed ID: 18201856
[TBL] [Abstract][Full Text] [Related]
9. China's biotech is starting to bloom.
Stipp D
Fortune; 2002 Sep; 146(4):126-30, 132, 134. PubMed ID: 12195673
[No Abstract] [Full Text] [Related]
10. 2011 in reflection.
Mullard A
Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
[No Abstract] [Full Text] [Related]
11. The biotechnology bubble machine.
Rasnick D
Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
[No Abstract] [Full Text] [Related]
12. Silent running: the race to the clinic.
Nature; 2006 Aug; 442(7103):614-5. PubMed ID: 16900171
[No Abstract] [Full Text] [Related]
13. Genomas: battling side effects with physiotypes.
McDonald J
Yale J Biol Med; 2007 Dec; 80(4):187-90. PubMed ID: 18449393
[No Abstract] [Full Text] [Related]
14. [Biotechnologies and gene engineering as priority trends in scientific-and-technological progress].
Vorob'ev AA
Vestn Ross Akad Med Nauk; 2004; (10):8-11. PubMed ID: 15575394
[No Abstract] [Full Text] [Related]
15. Leap of faith.
Morgan R
Mol Ther; 2014 Oct; 22(10):1717-8. PubMed ID: 25269938
[No Abstract] [Full Text] [Related]
16. Particularities of clinical investigation with biotechnology products.
Alsar MJ
Methods Find Exp Clin Pharmacol; 1999; 21 Suppl B():11-3. PubMed ID: 10599038
[No Abstract] [Full Text] [Related]
17. Profile - Robert Jackson interviewed by Suzanne Berry.
Jackson R
Trends Biotechnol; 2002 Nov; 20(11):485-6. PubMed ID: 12413824
[No Abstract] [Full Text] [Related]
18. Biotechs go generic: the same but different.
Ledford H
Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194
[No Abstract] [Full Text] [Related]
19. [Gene therapy in Germany: from past to present].
Kim Y; Schmidt-Wolf IG
Dtsch Med Wochenschr; 2015 Apr; 140(9):684-6. PubMed ID: 25924050
[TBL] [Abstract][Full Text] [Related]
20. Market watch: Therapeutic area 'heat map' for emerging markets.
Gautam A; Li L; Srinivasan K
Nat Rev Drug Discov; 2015 Aug; 14(8):518-9. PubMed ID: 26160486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
